These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9791153)

  • 1. Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation.
    Baiocchi L; Tisone G; Palmieri G; Rapicetta M; Pisani F; Orlando G; Casciani CU; Angelico M
    Liver Transpl Surg; 1998 Nov; 4(6):441-7. PubMed ID: 9791153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up.
    Zein NN; Rakela J; Poterucha JJ; Steers JL; Wiesner RH; Persing DH
    Liver Transpl Surg; 1995 Nov; 1(6):354-7. PubMed ID: 9346611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.
    Casavilla FA; Rakela J; Kapur S; Irish W; McMichael J; Demetris AJ; Starzl TE; Fung JJ
    Liver Transpl Surg; 1998 Nov; 4(6):448-54. PubMed ID: 9791154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection.
    Pageaux GP; Ducos J; Mondain AM; Costes V; Picot MC; Perrigault PF; Domergue J; Larrey D; Michel H
    Liver Transpl Surg; 1997 Sep; 3(5):501-5. PubMed ID: 9346792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation.
    Toniutto P; Fabris C; Avellini C; Minisini R; Bitetto D; Rossi E; Smirne C; Pirisi M
    World J Gastroenterol; 2005 Oct; 11(38):5944-50. PubMed ID: 16273604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
    Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.
    Sánchez-Fueyo A; Restrepo JC; Quintó L; Bruguera M; Grande L; Sánchez-Tapias JM; Rodés J; Rimola A
    Transplantation; 2002 Jan; 73(1):56-63. PubMed ID: 11792978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
    Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of hepatitis C virus infection after liver transplantation.
    Böker KH; Dalley G; Bahr MJ; Maschek H; Tillmann HL; Trautwein C; Oldhaver K; Bode U; Pichlmayr R; Manns MP
    Hepatology; 1997 Jan; 25(1):203-10. PubMed ID: 8985291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcome of hepatitis C virus infection after liver transplantation.
    Vargas V; Comas P; Castells L; Quer J; Esteban JI; Allende E; Esteban R; Guardia J; Margarit C
    Transpl Int; 1994; 7 Suppl 1():S216-20. PubMed ID: 11271206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.
    Costes V; Durand L; Pageaux GP; Ducos J; Mondain AM; Picot MC; Domergue J; Larrey D; Baldet P
    Am J Clin Pathol; 1999 Feb; 111(2):252-8. PubMed ID: 9930149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.